Jury Sides With Mayo in Joyner Case, and the COVID Messaging Muscle Memory Still Twitches

I still remember the 2020 vibe: every powerful institution humming like an overheated laptop, and everybody suddenly talking like they had to clear a sentence with a compliance officer before they cleared it with their own brain.

What the jury decided (and when)

On Feb. 12, 2026, an Olmsted County District Court jury in Minnesota sided with Mayo Clinic across the board in Dr. Michael Joyner‘s civil case, following a nine-day trial. The jury deliberated for about five hours and answered “No” to every question on the verdict form.

The core dispute, as summarized in Fox News: Joyner argued Mayo retaliated against him for criticizing the government’s COVID-19 response and for not sticking to what he described as “prescribed messaging” during the pandemic. He said leadership worried federal funding could be cut. Mayo denied retaliation and said discipline followed findings that he was rude and disrespectful toward coworkers and outside partners.

The specific claims the jury rejected

• That Mayo breached its anti-retaliation policy tied to a 2020 final written warning.
• That Joyner proved he reported or disclosed a compliance concern or wrongdoing in good faith and reasonably before the 2020 warning.
• That Joyner proved the same before the 2023 final written warning.
• That the 2023 warning relied on the 2020 warning.
• That Mayo’s appeal panel breached step 12 of its appeals procedure by not letting him submit additional information when he appealed the 2023 warning.

Why this fight grew bigger than one doctor

Post Bulletin reporting traced the roots back to June 2020, when Joyner led the nationwide Expanded Access Program for convalescent plasma. That program was funded by a $54 million grant from the Biomedical Advanced Research and Development Authority (BARDA).

Post Bulletin also reported that outside partners including MITRE Corp. and Epic had interest and some involvement in the program, and that Mayo’s Institutional Review Board formally sanctioned MITRE in September 2020 for two MITRE employees attempting to intimidate researchers on Joyner’s team into providing access to private patient data.

Discipline, conduct, and the courtroom scoreboard

Joyner said Mayo “weaponized” discipline in retaliation. Mayo’s lawyers argued discipline was about unprofessional behavior, including what they described as bullying communications staff and a 2020 ultimatum demanding millions of dollars within 48 hours or he would stop work on COVID-19 treatments. Joyner’s side argued the money demand was tied to a separate for-profit initiative to develop a product derived from convalescent plasma, with stress and long hours as context.

Mayo won. Joyner lost. And the larger argument still lingers: when federal dollars, reputations, and “messaging” all get fused together, who really gets to speak freely inside the institutions running American medicine?